Nama's AI scorecard currently rates Covista Buy (7.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CVSA's P/E ratio?

Covista trades at a trailing price-to-earnings ratio of 12.7.

When does CVSA report earnings?

Covista's next scheduled report is on Jan 28, 2027. Analysts expect EPS of $2.18.

What is the CVSA price target?

The median analyst price target from 4 analysts is $160.50, with a range of $140.00 – $175.00.

Is CVSA Shariah compliant?

Nama's AAOIFI-style screen reads Covista as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Covista (CVSA)

Consumer Defensive · Education Training Services · NYSE

Covista (CVSA) is a Consumer Defensive company in the Education Training Services industry. It has a market capitalization of $3.67B, a trailing price-to-earnings ratio of 12.7 and a free-cash-flow yield of 10.0%. Over the most recent reported fiscal year, revenue grew 9.3% and free cash flow per share grew 46.6%. Nama's AI scorecard rates it Buy, 7.7 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Buy · 7.7/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Rising · +33.8% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-29.4%

How far the last close sits under the highest price of the past five years.

Market cap	$3.67B
Trailing P/E	12.7
Price / book	2.6
Price / sales	1.8
FCF yield	10.0%
Dividend yield	—
Gross margin	57.3%
Operating margin	19.9%
Net margin	12.9%
Revenue growth (YoY)	+9.3%
Revenue growth (3-yr annual)	+10.4%
EPS growth (YoY)	+23.5%
FCF/share growth (YoY)	+46.6%
Beta	0.7
Exchange	NYSE
Sector	Consumer Defensive
Industry	Education Training Services

CVSA earnings

Next report: Jan 28, 2027 (Q2 2027, EPS estimate $2.18). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q1 2027	Oct 29, 2026	$2.19	$1.83	+19.7%	$511.53M
Q4 2026	Aug 6, 2026	$2.09	$1.89	+10.6%	$501.38M
Q3 2026	May 7, 2026	$1.98	$1.72	+15.1%	$487.03M
Q2 2026	Jan 28, 2026	$2.43	$2.19	+11.0%	$503.38M

CVSA analyst price target

Median target $160.50 from 4 analysts, ranging $140.00 – $175.00.

Education Training Services peers

Ticker	Company	Market cap	P/E
EDU	New Oriental Education & Technology Group	$8.53B	14.2
TAL	TAL Education Group	$5.64B	7.3
LAUR	Laureate Education	$4.56B	13.3
LRN	Stride	$3.15B	9.1
LOPE	Grand Canyon Education	$3.00B	12.2
DAO	Youdao	$2.38B	109.5
MH	McGraw Hill	$2.08B	5.6
PRDO	Perdoceo Education	$1.68B	8.8

Explore live CVSA data on Nama Insights →

CVSA FAQ

Is CVSA a buy?: Nama's AI scorecard currently rates Covista Buy (7.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CVSA's P/E ratio?: Covista trades at a trailing price-to-earnings ratio of 12.7.
When does CVSA report earnings?: Covista's next scheduled report is on Jan 28, 2027. Analysts expect EPS of $2.18.
What is the CVSA price target?: The median analyst price target from 4 analysts is $160.50, with a range of $140.00 – $175.00.
Is CVSA Shariah compliant?: Nama's AAOIFI-style screen reads Covista as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.